Chen Qihe, Xuan Guodong, Fu Mingliang, He Guoqing, Wang Wei, Zhang Hongbo, Ruan Hui
Department of Food Science and Nutrition, Zhejiang University, 268 Kaixuan Road, Hangzhou, Zhejiang, China 310029.
Asia Pac J Clin Nutr. 2007;16 Suppl 1:281-5.
Angiotensin I-converting enzyme (ACE) inhibitory peptide has good effect on blood pressure regulation. Therefore, research to find and develop safer, effective and economical ACE inhibitors is necessary for the prevention and remedy of hypertension. So food-derived ACE inhibitory peptides isolated from food or from enzymatic digestion of food proteins are the safe and efficient substitution for human health.
To investigate the effect of rice dreg enzymatic hydrolysates as an anti-hypertensive in vivo with spontaneous hypertension rats (SHRs).
The once-oral administration experiments with rice dreg hydrolysates peptide (RDHP) in different doses were conducted using 6 weeks old spontaneous hypertension rats as the test model. Twenty five SHRs were randomized into five groups according to blood-pressure level. The group A is blank control group, the group B positive control group (Captopril), the group C (1.0 mg/kg), the group D (RDHP 10 mg/kg) and group E (RDHP 50 mg/kg). The administration approach is to fill in stomach by mouth. The blood pressure value was observed for each group. The long term oral administration design was conducted for one month. Twenty four SHRs were randomized into 3 groups. The first group is the blank control, the second group is low dose (RDHP 10 mg/kg) and the third group is high dose (RDHP 20 mg/kg). In administration period, blood pressure was measured for once a week.
The once-oral administration animal experiments showed that the blood pressure of SHR drop was 11 mmHg, 17 mmHg, 26.00 mmHg, 17 mmHg at a dosage of 1 mg/kg, 10 mg/kg, 50 mg/kg hydrolysates and 1 mg/kg captopril, respectively, after 1h administration. The results of long-term oral administration indicated that the blood pressure drop was 17 mmHg, 26 mmHg in 10 mg/kg and 20 mg/kg, respectively after 30 days administration. RDHP not only promoted the growth of SHR, but also had no adverse effect on heart rate.
The present study indicated the inhibitory peptides from rice dreg hydrolysate had significant antihypertensive action and no other side effects by oral administration in SHR.
血管紧张素I转换酶(ACE)抑制肽对血压调节有良好作用。因此,寻找和开发更安全、有效且经济的ACE抑制剂对于高血压的防治十分必要。所以从食物或食物蛋白酶解物中分离得到的食物源ACE抑制肽是对人体健康安全有效的替代品。
以自发性高血压大鼠(SHR)为实验对象,研究米渣酶解物的体内降压效果。
以6周龄自发性高血压大鼠为实验模型,进行米渣水解物肽(RDHP)不同剂量的单次灌胃给药实验。25只SHR根据血压水平随机分为5组。A组为空白对照组,B组为阳性对照组(卡托普利),C组(1.0毫克/千克),D组(RDHP 10毫克/千克)和E组(RDHP 50毫克/千克)。给药途径为灌胃。观察每组大鼠的血压值。进行为期1个月的长期灌胃给药设计。24只SHR随机分为3组。第一组为空白对照组,第二组为低剂量组(RDHP 10毫克/千克),第三组为高剂量组(RDHP 20毫克/千克)。给药期间,每周测量一次血压。
单次灌胃给药动物实验显示,给药1小时后,1毫克/千克、10毫克/千克、50毫克/千克水解物及1毫克/千克卡托普利剂量下SHR的血压下降值分别为11毫米汞柱、17毫米汞柱、26.00毫米汞柱、17毫米汞柱。长期灌胃给药结果表明,给药30天后,10毫克/千克和20毫克/千克剂量下的血压下降值分别为17毫米汞柱、26毫米汞柱。RDHP不仅促进了SHR的生长,而且对心率无不良影响。
本研究表明,米渣水解物中的抑制肽经口服对SHR有显著降压作用且无其他副作用。